249 related articles for article (PubMed ID: 24343899)
1. Intestinal CYP3A4 protects against lithocholic acid-induced hepatotoxicity in intestine-specific VDR-deficient mice.
Cheng J; Fang ZZ; Kim JH; Krausz KW; Tanaka N; Chiang JY; Gonzalez FJ
J Lipid Res; 2014 Mar; 55(3):455-65. PubMed ID: 24343899
[TBL] [Abstract][Full Text] [Related]
2. Role of vitamin D receptor in the lithocholic acid-mediated CYP3A induction in vitro and in vivo.
Matsubara T; Yoshinari K; Aoyama K; Sugawara M; Sekiya Y; Nagata K; Yamazoe Y
Drug Metab Dispos; 2008 Oct; 36(10):2058-63. PubMed ID: 18645036
[TBL] [Abstract][Full Text] [Related]
3. Molecular and functional comparison of 1,25-dihydroxyvitamin D(3) and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3A4.
Jurutka PW; Thompson PD; Whitfield GK; Eichhorst KR; Hall N; Dominguez CE; Hsieh JC; Haussler CA; Haussler MR
J Cell Biochem; 2005 Apr; 94(5):917-43. PubMed ID: 15578590
[TBL] [Abstract][Full Text] [Related]
4. The role of lithocholic acid in the regulation of bile acid detoxication, synthesis, and transport proteins in rat and human intestine and liver slices.
Khan AA; Chow EC; Porte RJ; Pang KS; Groothuis GM
Toxicol In Vitro; 2011 Feb; 25(1):80-90. PubMed ID: 20888898
[TBL] [Abstract][Full Text] [Related]
5. Lignans from Schisandra sphenanthera protect against lithocholic acid-induced cholestasis by pregnane X receptor activation in mice.
Fan S; Liu C; Jiang Y; Gao Y; Chen Y; Fu K; Yao X; Huang M; Bi H
J Ethnopharmacol; 2019 Dec; 245():112103. PubMed ID: 31336134
[TBL] [Abstract][Full Text] [Related]
6. Intestinal detoxification limits the activation of hepatic pregnane X receptor by lithocholic acid.
Owen BM; Milona A; van Mil S; Clements P; Holder J; Boudjelal M; Cairns W; Parker M; White R; Williamson C
Drug Metab Dispos; 2010 Jan; 38(1):143-9. PubMed ID: 19797606
[TBL] [Abstract][Full Text] [Related]
7. Pregnane X receptor mediated-transcription regulation of CYP3A by glycyrrhizin: a possible mechanism for its hepatoprotective property against lithocholic acid-induced injury.
Wang YG; Zhou JM; Ma ZC; Li H; Liang QD; Tan HL; Xiao CR; Zhang BL; Gao Y
Chem Biol Interact; 2012 Oct; 200(1):11-20. PubMed ID: 22982774
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D Receptor Deletion Changes Bile Acid Composition in Mice Orally Administered Chenodeoxycholic Acid.
Nishida S; Ishizawa M; Kato S; Makishima M
J Nutr Sci Vitaminol (Tokyo); 2020; 66(4):370-374. PubMed ID: 32863311
[TBL] [Abstract][Full Text] [Related]
9. Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative.
Adachi R; Honma Y; Masuno H; Kawana K; Shimomura I; Yamada S; Makishima M
J Lipid Res; 2005 Jan; 46(1):46-57. PubMed ID: 15489543
[TBL] [Abstract][Full Text] [Related]
10. Lithocholic Acid Is a Vitamin D Receptor Ligand That Acts Preferentially in the Ileum.
Ishizawa M; Akagi D; Makishima M
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986424
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D Receptor Mediates Attenuating Effect of Lithocholic Acid on Dextran Sulfate Sodium Induced Colitis in Mice.
Kubota H; Ishizawa M; Kodama M; Nagase Y; Kato S; Makishima M; Sakurai K
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834927
[TBL] [Abstract][Full Text] [Related]
12. Lithocholic acid feeding results in direct hepato-toxicity independent of neutrophil function in mice.
Woolbright BL; Li F; Xie Y; Farhood A; Fickert P; Trauner M; Jaeschke H
Toxicol Lett; 2014 Jul; 228(1):56-66. PubMed ID: 24742700
[TBL] [Abstract][Full Text] [Related]
13. Intestinal cell-specific vitamin D receptor (VDR)-mediated transcriptional regulation of CYP3A4 gene.
Pavek P; Pospechova K; Svecova L; Syrova Z; Stejskalova L; Blazkova J; Dvorak Z; Blahos J
Biochem Pharmacol; 2010 Jan; 79(2):277-87. PubMed ID: 19712670
[TBL] [Abstract][Full Text] [Related]
14. Implication of intestinal VDR deficiency in inflammatory bowel disease.
Kim JH; Yamaori S; Tanabe T; Johnson CH; Krausz KW; Kato S; Gonzalez FJ
Biochim Biophys Acta; 2013 Jan; 1830(1):2118-28. PubMed ID: 23041070
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D receptor-dependent regulation of colon multidrug resistance-associated protein 3 gene expression by bile acids.
McCarthy TC; Li X; Sinal CJ
J Biol Chem; 2005 Jun; 280(24):23232-42. PubMed ID: 15824121
[TBL] [Abstract][Full Text] [Related]
16. Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcemia.
Ishizawa M; Matsunawa M; Adachi R; Uno S; Ikeda K; Masuno H; Shimizu M; Iwasaki K; Yamada S; Makishima M
J Lipid Res; 2008 Apr; 49(4):763-72. PubMed ID: 18180267
[TBL] [Abstract][Full Text] [Related]
17. Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention.
Bartik L; Whitfield GK; Kaczmarska M; Lowmiller CL; Moffet EW; Furmick JK; Hernandez Z; Haussler CA; Haussler MR; Jurutka PW
J Nutr Biochem; 2010 Dec; 21(12):1153-61. PubMed ID: 20153625
[TBL] [Abstract][Full Text] [Related]
18. Rapid and drastic induction of CYP3A4 mRNA expression via vitamin D receptor in human intestinal LS180 cells.
Fukumori S; Murata T; Taguchi M; Hashimoto Y
Drug Metab Pharmacokinet; 2007 Oct; 22(5):377-81. PubMed ID: 17965521
[TBL] [Abstract][Full Text] [Related]
19. The protective effect of lithocholic acid on the intestinal epithelial barrier is mediated by the vitamin D receptor via a SIRT1/Nrf2 and NF-κB dependent mechanism in Caco-2 cells.
Yao B; He J; Yin X; Shi Y; Wan J; Tian Z
Toxicol Lett; 2019 Nov; 316():109-118. PubMed ID: 31472180
[TBL] [Abstract][Full Text] [Related]
20. Regulation of VDR expression in rat and human intestine and liver--consequences for CYP3A expression.
Khan AA; Dragt BS; Porte RJ; Groothuis GM
Toxicol In Vitro; 2010 Apr; 24(3):822-9. PubMed ID: 20006981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
